BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28213000)

  • 1. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC).
    Lam VK; Bentzen SM; Mohindra P; Nichols EM; Bhooshan N; Vyfhuis M; Scilla KA; Feigenberg SJ; Edelman MJ; Feliciano JL
    Lung Cancer; 2017 Feb; 104():52-57. PubMed ID: 28213000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
    Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
    Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery.
    Nakagawa T; Toyazaki T; Chiba N; Ueda Y; Gotoh M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):560-6. PubMed ID: 27252238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.
    Mitsuyoshi T; Matsuo Y; Itou H; Shintani T; Iizuka Y; Kim YH; Mizowaki T
    J Radiat Res; 2018 Jan; 59(1):50-57. PubMed ID: 29182777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer.
    Morel H; Raynard B; d'Arlhac M; Hauss PA; Lecuyer E; Oliviero G; Marty C; Gury JP; Asselain B; Grivaux M; Debieuvre D
    Lung Cancer; 2018 Dec; 126():55-63. PubMed ID: 30527193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of body mass index and outcomes following lobectomy for non-small-cell lung cancer.
    Wang C; Guo M; Zhang N; Wang G
    World J Surg Oncol; 2018 May; 16(1):90. PubMed ID: 29751759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
    Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
    Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients.
    Masel EK; Berghoff AS; Füreder LM; Heicappell P; Schlieter F; Widhalm G; Gatterbauer B; Dieckmann U; Birner P; Bartsch R; Schur S; Watzke HH; Zielinski CC; Preusser M
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28488812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials.
    Dahlberg SE; Schiller JH; Bonomi PB; Sandler AB; Brahmer JR; Ramalingam SS; Johnson DH
    J Thorac Oncol; 2013 Sep; 8(9):1121-7. PubMed ID: 23887169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients.
    Kang J; Lee SH; Son JH; Lee JW; Choi YH; Choi JH; Paik WH; Ryu JK; Kim YT
    PLoS One; 2018; 13(4):e0195118. PubMed ID: 29608578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
    Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH
    Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
    Sher DJ; Gielda BT; Liptay MJ; Warren WH; Batus M; Fidler MJ; Garg S; Bonomi P
    Clin Lung Cancer; 2013 Jul; 14(4):370-5. PubMed ID: 23260389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body Mass Index as a Prognostic Factor in Resected Lung Cancer: Obesity or Underweight, Which Is the Risk Factor?
    Matsunaga T; Suzuki K; Imashimizu K; Banno T; Takamochi K; Oh S
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):551-7. PubMed ID: 26277079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer.
    Li R; Hermann G; Baldini E; Chen A; Jackman D; Kozono D; Nguyen P; Nohria A; Powell G; Mak R
    Lung Cancer; 2016 Jun; 96():41-7. PubMed ID: 27133748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
    Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
    Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex relationship of body mass index with mortality in patients with critical limb ischemia undergoing endovascular treatment.
    Murata N; Soga Y; Iida O; Yamauchi Y; Hirano K; Kawasaki D; Fujihara M; Tomoi Y
    Eur J Vasc Endovasc Surg; 2015 Mar; 49(3):297-305. PubMed ID: 25524520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.
    Shepshelovich D; Xu W; Lu L; Fares A; Yang P; Christiani D; Zhang J; Shiraishi K; Ryan BM; Chen C; Schwartz AG; Tardon A; Wu X; Schabath MB; Teare MD; Le Marchand L; Zhang ZF; Field JK; Brenner H; Diao N; Xie J; Kohno T; Harris CC; Wenzlaff AS; Fernandez-Tardon G; Ye Y; Taylor F; Wilkens LR; Davies M; Liu Y; Barnett MJ; Goodman GE; Morgenstern H; Holleczek B; Brown MC; Liu G; Hung RJ
    J Thorac Oncol; 2019 Sep; 14(9):1594-1607. PubMed ID: 31163278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment and prognosis of advanced stage non-small-cell lung cancer].
    Chermiti Ben Abdallah F; Ben Ali G; Sadok Boudaya M; Mlika M; Chtourou A; Taktak S; Ben Kheder A
    Rev Mal Respir; 2014 Mar; 31(3):214-20. PubMed ID: 24680112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.